Biotech’s Historic Month (And Whether It Can Last)
After three straight months of losses, April brought the S&P 500 health care sector its best one-month gain in twenty years, and today’s article notes…
More Evidence That Biotech Is The “Next Gold Mine”
If you need any further evidence of just how much the COVID-19 pandemic has increased the allure of biotechnology stocks, consider the little-known Chinese biotech…
Are These Biotech And Energy Stocks The Best Penny Stock Picks Right Now?
In the world of penny stocks, biotech penny stocks and energy penny stocks have been among the big movers recently – and the author of…
3 “Compelling” Biotech Stocks With Small Price Tags And Big Upside Potential
In assessing the current market environment, the author of today’s article notes that “it becomes apparent that there’s an opportunity for those able to take…
What Are Insiders Seeing In This Clinical-Stage Biotech?
The clinical-stage biopharmaceutical company highlighted in today’s article is focused on the development of novel therapies for cardio-metabolic disease, liver disease, ophthalmic disease and cancer…
3 Penny Stocks With High Profit Potential
Considering the state of affairs right now, investors may be reluctant to buy expensive stocks. Thankfully, there’s penny stocks. As the author of today’s article…
“Imminent Danger”: These 4 Energy Stocks Could Be Kicked Out Of The S&P 500
Thanks to it ensuring a ready supply of buyers, buying stocks that are about to be included in the S&P 500 has proven to be…
Don’t Overlook This Cancer Biotech In The Age Of Coronavirus
This clinical-stage biopharmaceutical company focused on developing treatments for different kinds of cancers just recently launched an IPO, making it just the second IPO to…
Gain Exposure To Small- And Mid-Cap Companies On The Cutting Edge Of Healthcare With This ETF
If exposure to cutting-edge innovations in the healthcare industry is what you’re after, consider the exchange-traded fund highlighted in today’s article, which focuses on potential…
This Diagnostics Company’s CEO Is Buying Up Shares On The News Of Its COVID-19 Testing Partnership
As testing for COVID-19 in the U.S. (or lack thereof) has been a much-discussed topic over the past month, shares of one diagnostics and pharmaceutical…